SeaStar Medical Holding Corporation is a medical technology company based in Denver, CO that is revolutionizing extracorporeal therapies to combat excessive inflammation and its impact on vital organs. Through their innovative cell-directed extracorporeal therapy, SeaStar Medical aims to prevent the devastating effects of a cytokine storm, a hyperinflammatory response that can cause severe organ damage and even death. Their patented technology transforms inflammatory messengers into agents of repair, improving patient outcomes and potentially reversing injury.
With a focus on reducing dialysis dependency, improving outcomes, and saving lives, SeaStar Medical's groundbreaking solutions seamlessly integrate into critical-care workflows, providing healthcare professionals with the power to combat this serious clinical threat. Backed by rigorous clinical research and scientific evidence, SeaStar Medical's novel approach offers a simple and effective way to rescue patients from cytokine storms, regardless of the trigger, and restore reparative functionality to the body.
Generated from the website